News
NIH inventors have developed a new strategy of using Interleukin 24 (IL-24) to target the whole T-helper 17 cells (Th17) lineage and thus achieve improved efficacy in therapy of Th17-relevant autoimmune diseases such as uveitis, multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. The Th17
The NIH Office of Technology Transfer is now accepting applications for an IRTA Fellowship position. This fellowship will enable a qualified candidate to combine their science background with training and experience in the technology transfer field. Fellows work with OTT marketing, patenting, and
The NIH Office of Technology Transfer (OTT) has announced the licensing of US government-owned patents to the Medicines Patent Pool (MPP) as a contribution to a voluntary patent pool for antiretroviral medicines (ARVs) designed to facilitate access to HIV treatment in developing countries. This
The technology is an exciting discovery in the field of prostate, breast and lung cancer genetic markers having profound clinical applications in defining the optimal chemotherapeutic treatment schedule for each individual patient. This genetic marker (CYP1B1*3) can potentially be used as a